Challenges and opportunities in using residual newborn screening samples for translational research

By Steve Olson, Adam C. Berger

Subjects: Bioethical Issues, Neonatal Screening, Research, Newborn infants, Infants (newborn), Diseases, Inborn Genetic Diseases, Public Health, Newborn Infant, Blood Chemical Analysis, Moral and ethical aspects, Diagnosis, Blood Specimen Collection, Neonatology, Translational Medical Research, Ethics, Biomedical Research

Description: "Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research."